Sartorius to acquire recombinant albumin-based solutions provider Albumedix
Sartorius Group, a German pharma and lab equipment supplier, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire privately-held biotech company Albumedix for a price of around £415 million. Based in Nottingham, UK, Albumedix provides recombinant albumin-based solutions. According to Sartorius, recombinant human albumin is a major component for the biopharma industry, […]